EUVIMEDEUVIMED entdecken
Open Access

The combination of a PTP1B inhibitor, TNFR2 blocker, and PD‑1 antibody suppresses the progression of non‑small cell lung cancer tumors by enhancing immunocompetence

Huan Gui, Yujie Nie, Haohua Yuan, Qianyu Jing, Linzhao Li, Lan Zhu, Shuanghui Chen, Mengjiao Wang, Quan Wan, Hang Lv, Yingjie Nie, Xiangyan Zhang

Oncology Reports · 2024

DOI: 10.3892/or.2024.8808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2024. Verfasst von Huan Gui und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Guizhou University, Guiyang, Guizhou 550025, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Receptors, Tumor Necrosis Factor, Type II, Protein Tyrosine Phosphatase, Non-Receptor Type 1, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungReceptors, Tumor Necrosis Factor, Type IIProtein Tyrosine Phosphatase, Non-Receptor Type 1Lung NeoplasmsProgrammed Cell Death 1 ReceptorImmune Checkpoint InhibitorsAnimalsMiceHumansCell Line, TumorDisease ProgressionFemaleImmunotherapyAntineoplastic Combined Chemotherapy ProtocolsB7-H1 Antigen

Stichwörter der Autor:innen

CD8+T cellscombination immunotherapynon‑small cell lung cancerprogrammed cell death 1protein tyrosine phosphatase 1Btumor necrosis factor receptor 2

Substanzen

Receptors, Tumor Necrosis Factor, Type IIProtein Tyrosine Phosphatase, Non-Receptor Type 1Programmed Cell Death 1 ReceptorImmune Checkpoint InhibitorsTnfrsf1b protein, mouseB7-H1 Antigen

Autor:innen und Institutionen

  • School of Medicine, Guizhou University, Guiyang, Guizhou 550025, P.R. China.
  • NHC Key Laboratory of Pulmonary Immunological Diseases, Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, P.R. China.

Zitieren

APA

Gui, H., Nie, Y., Yuan, H., Jing, Q., Li, L., Zhu, L., Chen, S., Wang, M., Wan, Q., Lv, H., Nie, Y., & Zhang, X. (2024). The combination of a PTP1B inhibitor, TNFR2 blocker, and PD‑1 antibody suppresses the progression of non‑small cell lung cancer tumors by enhancing immunocompetence. Oncology Reports. https://doi.org/10.3892/or.2024.8808

Vancouver

Gui H, Nie Y, Yuan H, Jing Q, Li L, Zhu L, et al. The combination of a PTP1B inhibitor, TNFR2 blocker, and PD‑1 antibody suppresses the progression of non‑small cell lung cancer tumors by enhancing immunocompetence. Oncology Reports. 2024. doi:10.3892/or.2024.8808

BibTeX
@article{Gui2024,
  author = {Gui, Huan and Nie, Yujie and Yuan, Haohua and Jing, Qianyu and Li, Linzhao and Zhu, Lan and Chen, Shuanghui and Wang, Mengjiao and Wan, Quan and Lv, Hang and Nie, Yingjie and Zhang, Xiangyan},
  title = {The combination of a PTP1B inhibitor, TNFR2 blocker, and PD‑1 antibody suppresses the progression of non‑small cell lung cancer tumors by enhancing immunocompetence},
  journal = {Oncology Reports},
  year = {2024},
  doi = {10.3892/or.2024.8808}
}
Kostenlos starten →